Autopsy report · NCT00612911

Cell Therapy in Dilated Cardiomyopathy: Observational Study

“finish study as protocol”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 years 11 months after it had already started.
• Ran for about 2 years 6 months before it stopped.
• 24 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Ministry of Health, Brazil

Sponsor type

Government (non-US federal)

Conditions

Cardiomyopathy, Dilated

Interventions

Cell therapy

Participants

24

Sites

1

Countries

Brazil

Trials that died the same way

• OsseoFit™ Prospective Data Collection
  “Planning new study protocol” (76% match in meaning)
• Safety and Effectiveness Study of RF Ablation of Uterine Fibroids to Reduce Menstrual Bleeding: the Fibroid Ablation Study
  “study revised and reinitiated under another protocol” (72% match in meaning)
• Estimate Serum Oxytocin PD Range in the Periphery
  “Study will be replaced by a revised study protocol” (71% match in meaning)
• Effects of Whole Food, Plant-Based Nutrition on Chronic Kidney Disease With Proteinuria
  “Substantially redesigning study protocol and opening a new study in the future.” (70% match in meaning)
• Treatment of Balance Disorders in Parkinson's Patients Using SpotOn Balance Glasses
  “The study protocol needed to be modified” (68% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.